DBV Technologies and Stallergenes, S.A. (GENP.PA) Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies
5/17/2013 10:25:44 AM
More...
|
Aerocrine and Stallergenes, S.A. (GENP.PA) Sign Exclusive Distribution Agreement for NIOX MINO®
8/28/2012 9:47:52 AM
More...
|
Stallergenes, S.A. (GENP.PA) Release: 1st Half-Year 2012: Sales Up 6% Solid Performance in a Sensitive Economic Situation
7/12/2012 11:49:13 AM
More...
|
Ares Life SciencesHolds 73.18% of the Capital and Voting Rights of Stallergenes, S.A. (GENP.PA) At the End of the Offering Period
3/17/2011 11:13:57 AM
More...
|
Ares Life Sciences to Launch Full Buyout of Stallergenes, S.A. (GENP.PA)
11/17/2010 6:44:57 AM
More...
|
Ares Life Sciences Signs an Agreement to Acquire 45.86% Stake in Stallergenes, S.A. (GENP.PA) From Wendel; Transaction to Close in the Coming Days
11/10/2010 1:50:42 PM
More...
|
Stallergenes, S.A. (GENP.PA) Announces Positive Results for Oralair(R) Phase III Trial in the USA
4/19/2010 6:38:53 AM
More...
|
Stallergenes, S.A. (GENP.PA): Oralair: Very Positive 3-Year Results of the Long-Term Study
12/7/2009 11:44:15 AM
More...
|
Stallergenes, S.A. (GENP.PA) is Granted a Marketing Authorization for Oralair(R) in Europe
11/30/2009 8:32:46 AM
More...
|
Stallergenes, S.A. (GENP.PA) Continued Dynamic Growth / Cumulative Sales to the end of September 2009 up 12%
10/16/2009 8:50:48 AM
More...
|
|